Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 1/2007

01.01.2007 | Head and Neck

Injection tongueplasty: effects of sclerosant OK-432 on rat tongue

verfasst von: Gurkan Keskin, Sinem Keskin, Omer Aydin, Yesim Gurbuz, Emre Ustundag

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Our aim was to investigate the effect of sclerosant agent OK-432 on tongue fibrosis and to determine whether the fibrosis formed by this substance increases with dose. Fifty Wistar albino rats were divided into three groups for the study. In the first group 0.2 ml OK-432, in the second group 0.5 ml OK-432, and in the third group physiological saline as the control substance was injected into the tongue of these rats. Subjects were sacrificed on the first day, first week, first month, third month and sixth month following the injection. Cross-sections of the tongues were stained with hematoxylin–eosin (HE) and Masson Tri-chrome. The degree of fibrosis was measured using ocular micrometry. A significant amount of fibrosis was observed in both the 0.2 ml (P = 0.020) and 0.5 ml (P = 0.003) OK-432 injection groups. OK-432 is a material that causes significant fibrosis in the muscle when compared to physiological saline. The degree of fibrosis in the tongue increases with dose.
Literatur
1.
Zurück zum Zitat Mickelson SA (1996) Laser-assisted uvulopalatoplasty for obstructive sleep apnea. Laryngoscope 106:10–13PubMedCrossRef Mickelson SA (1996) Laser-assisted uvulopalatoplasty for obstructive sleep apnea. Laryngoscope 106:10–13PubMedCrossRef
2.
Zurück zum Zitat Woodson BT, Fujita S (1992) Clinical experience with lingualplasty as part of the treatment of severe obstructive sleep apnea. Otolaryngol Head Neck Surg 107:40–48PubMed Woodson BT, Fujita S (1992) Clinical experience with lingualplasty as part of the treatment of severe obstructive sleep apnea. Otolaryngol Head Neck Surg 107:40–48PubMed
3.
Zurück zum Zitat Powell N, Guilleminault C, Riley R, Smith L (1983) Mandibular advancement and obstructive sleep apnea syndrome. Bull Eur Physiopathol Respir 19:607–610PubMed Powell N, Guilleminault C, Riley R, Smith L (1983) Mandibular advancement and obstructive sleep apnea syndrome. Bull Eur Physiopathol Respir 19:607–610PubMed
4.
Zurück zum Zitat Eisele D, Schwartz A, Smith PL (2003) Tongue neuromuscular and direct hypoglossal nerve stimulation for obstructive sleep apnea. Otolaryngol Clin N Am 36:501–510CrossRef Eisele D, Schwartz A, Smith PL (2003) Tongue neuromuscular and direct hypoglossal nerve stimulation for obstructive sleep apnea. Otolaryngol Clin N Am 36:501–510CrossRef
5.
Zurück zum Zitat Brietzke SE, Mair EA (2003) Injection snoreplasty: extended follow-up and new objective data. Otolaryngol Head Neck Surg 128:605–615PubMedCrossRef Brietzke SE, Mair EA (2003) Injection snoreplasty: extended follow-up and new objective data. Otolaryngol Head Neck Surg 128:605–615PubMedCrossRef
6.
Zurück zum Zitat Brietzke SE, Mair EA (2004) Injection snoreplasty: investigation of alternative sclerotherapy agents. Otolaryngol Head Neck Surg 130:47–57PubMedCrossRef Brietzke SE, Mair EA (2004) Injection snoreplasty: investigation of alternative sclerotherapy agents. Otolaryngol Head Neck Surg 130:47–57PubMedCrossRef
7.
Zurück zum Zitat Rutherford A (2000) Varicose veins: treatment by surgery and sclerotherapy. In: Coronenwelt, Gloricks, Kripski (eds) Vascular surgery, 1st edn. Saunders, Philedelphia, p 2015 Rutherford A (2000) Varicose veins: treatment by surgery and sclerotherapy. In: Coronenwelt, Gloricks, Kripski (eds) Vascular surgery, 1st edn. Saunders, Philedelphia, p 2015
8.
Zurück zum Zitat Nishida R, Inoue R, Takimoto Y, Kita T (1999) A sclerosant with astringent properties developed in China for oesophageal varices: comparison with ethanolamine oleate and polidocanol. J Gastroenterol Hepatol 14:481–488PubMedCrossRef Nishida R, Inoue R, Takimoto Y, Kita T (1999) A sclerosant with astringent properties developed in China for oesophageal varices: comparison with ethanolamine oleate and polidocanol. J Gastroenterol Hepatol 14:481–488PubMedCrossRef
9.
Zurück zum Zitat Brietzke SE, Mair EA (2001) Injection snoreplasty: how to treat snoring without all the pain and expense. Otolaryngol Head Neck Surg 124:503–510PubMedCrossRef Brietzke SE, Mair EA (2001) Injection snoreplasty: how to treat snoring without all the pain and expense. Otolaryngol Head Neck Surg 124:503–510PubMedCrossRef
10.
Zurück zum Zitat Ogita S, Tsutu T, Tokiwa T (1994) OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg 29:784–785PubMedCrossRef Ogita S, Tsutu T, Tokiwa T (1994) OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg 29:784–785PubMedCrossRef
11.
Zurück zum Zitat Toyota B (1967) Clinical effects of a streptococal preparation OK-432 against head and neck cancer. Jpn J Otol 72:1332–1338 Toyota B (1967) Clinical effects of a streptococal preparation OK-432 against head and neck cancer. Jpn J Otol 72:1332–1338
12.
Zurück zum Zitat Ogita S, Tsutu T, Tokiwa T (1987) Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. B J Surg 74:690–691CrossRef Ogita S, Tsutu T, Tokiwa T (1987) Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. B J Surg 74:690–691CrossRef
13.
Zurück zum Zitat Mikhail M, Kennedy R, Cramer B (1995) Sclerosing of recurrent lympangioma using OK-432. J Pediatr Surg 30:1159–1160PubMedCrossRef Mikhail M, Kennedy R, Cramer B (1995) Sclerosing of recurrent lympangioma using OK-432. J Pediatr Surg 30:1159–1160PubMedCrossRef
14.
Zurück zum Zitat Fukase S, Ohta N, Inamura K, Aoyagi N (2003) Treatment of ranula with intracystic injection of the streptococcal preparation OK-432. Ann Otol Rhinol Laryngol 112:214–220PubMed Fukase S, Ohta N, Inamura K, Aoyagi N (2003) Treatment of ranula with intracystic injection of the streptococcal preparation OK-432. Ann Otol Rhinol Laryngol 112:214–220PubMed
15.
Zurück zum Zitat Ogita S, Tsuto T, Deguchi E, Tokiwa K, Nagashima M, Iwai N (1991) OK-432 treatment for unresectable lymphangiomas in children. J Pediatr Surg 26:263–270PubMedCrossRef Ogita S, Tsuto T, Deguchi E, Tokiwa K, Nagashima M, Iwai N (1991) OK-432 treatment for unresectable lymphangiomas in children. J Pediatr Surg 26:263–270PubMedCrossRef
16.
Zurück zum Zitat Ogita S, Tsuto T, Nakamura K, Deguchi E, Tokiwa K, Iwai N (1996) OK-432 treatment for unresectable lymphangiomas in children: Why and how does it work? J Pediatr Surg 31:477–480PubMedCrossRef Ogita S, Tsuto T, Nakamura K, Deguchi E, Tokiwa K, Iwai N (1996) OK-432 treatment for unresectable lymphangiomas in children: Why and how does it work? J Pediatr Surg 31:477–480PubMedCrossRef
17.
Zurück zum Zitat Ogita S, Tsuto T, Tokiwa K, Takahashi T (1987) Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Br J Surg 74:690–691PubMedCrossRef Ogita S, Tsuto T, Tokiwa K, Takahashi T (1987) Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Br J Surg 74:690–691PubMedCrossRef
18.
Zurück zum Zitat Naik B, Lobato E (2004) Acute cardiovascular instability during percutaneous ethanol injection of a hepatocellular carcinoma under general anesthesia. Anesthesiology 100:1307–1308PubMedCrossRef Naik B, Lobato E (2004) Acute cardiovascular instability during percutaneous ethanol injection of a hepatocellular carcinoma under general anesthesia. Anesthesiology 100:1307–1308PubMedCrossRef
19.
Zurück zum Zitat Shiina S, Teratani T, Obi S, Hamamura K, Koike Y, Omata M (2002) Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 62(suppl 1):64–68PubMedCrossRef Shiina S, Teratani T, Obi S, Hamamura K, Koike Y, Omata M (2002) Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 62(suppl 1):64–68PubMedCrossRef
20.
Zurück zum Zitat Bowes L, Goldman MP (2002) Sclerothearpy of reticular and telengiectatic veins of the face, hands and chest. Dermatol Surg 28:46–51PubMedCrossRef Bowes L, Goldman MP (2002) Sclerothearpy of reticular and telengiectatic veins of the face, hands and chest. Dermatol Surg 28:46–51PubMedCrossRef
21.
Zurück zum Zitat Smith RJ, Burke DK, Sato Y, Poust RI, Kimura K, Bauman NM (1996) OK-432 therapy for lymphangiomas. Arch Otolaryngol Head Neck Surg 122:1195–1199PubMed Smith RJ, Burke DK, Sato Y, Poust RI, Kimura K, Bauman NM (1996) OK-432 therapy for lymphangiomas. Arch Otolaryngol Head Neck Surg 122:1195–1199PubMed
22.
Zurück zum Zitat Powell N, Riley R, Guilleminault C (1999) Radiofrequency tongue base reduction in sleep-disordered breathing: a pilot study. Otolaryngol Head Neck Surg 120:656–664PubMedCrossRef Powell N, Riley R, Guilleminault C (1999) Radiofrequency tongue base reduction in sleep-disordered breathing: a pilot study. Otolaryngol Head Neck Surg 120:656–664PubMedCrossRef
23.
Zurück zum Zitat Li KK, Powell NB, Riley RW, Troell RJ, Guilleminault C (2000) Radiofrequency volumetric reduction of the palate: an extended follow-up study. Otolaryngol Head Neck Surg 122:410–414PubMedCrossRef Li KK, Powell NB, Riley RW, Troell RJ, Guilleminault C (2000) Radiofrequency volumetric reduction of the palate: an extended follow-up study. Otolaryngol Head Neck Surg 122:410–414PubMedCrossRef
Metadaten
Titel
Injection tongueplasty: effects of sclerosant OK-432 on rat tongue
verfasst von
Gurkan Keskin
Sinem Keskin
Omer Aydin
Yesim Gurbuz
Emre Ustundag
Publikationsdatum
01.01.2007
Verlag
Springer-Verlag
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 1/2007
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-006-0136-5

Weitere Artikel der Ausgabe 1/2007

European Archives of Oto-Rhino-Laryngology 1/2007 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.